US5160744A
(en)
*
|
1991-06-27 |
1992-11-03 |
Alza Corporation |
Verapmil therapy
|
US6764697B1
(en)
*
|
1991-06-27 |
2004-07-20 |
Alza Corporation |
System for delaying drug delivery up to seven hours
|
GB9117361D0
(en)
*
|
1991-08-12 |
1991-09-25 |
Euro Celtique Sa |
Oral dosage form
|
FI93924C
(fi)
*
|
1991-09-17 |
1995-06-26 |
Martti Lauri Antero Marvola |
Menetelmä säädellysti lääkeainetta vapauttavan valmisteen valmistamiseksi
|
US5422122A
(en)
*
|
1992-08-04 |
1995-06-06 |
Eurand America, Incorporated |
Controlled release potassium chloride tablet
|
NZ255579A
(en)
*
|
1992-09-18 |
1996-03-26 |
Yamanouchi Pharma Co Ltd |
Sustained release hydrogel pharmaceutical formulation
|
DE69425453T2
(de)
*
|
1993-04-23 |
2001-04-12 |
Novartis Ag, Basel |
Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
|
US6440457B1
(en)
*
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US5922736A
(en)
*
|
1995-12-04 |
1999-07-13 |
Celegene Corporation |
Chronic, bolus administration of D-threo methylphenidate
|
US5837284A
(en)
|
1995-12-04 |
1998-11-17 |
Mehta; Atul M. |
Delivery of multiple doses of medications
|
US6486177B2
(en)
*
|
1995-12-04 |
2002-11-26 |
Celgene Corporation |
Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate
|
US6096339A
(en)
*
|
1997-04-04 |
2000-08-01 |
Alza Corporation |
Dosage form, process of making and using same
|
US6919373B1
(en)
|
1996-11-12 |
2005-07-19 |
Alza Corporation |
Methods and devices for providing prolonged drug therapy
|
EP1782798A3
(en)
|
1996-11-25 |
2008-05-21 |
Alza Corporation |
Ascending-dose dosage form
|
CA2265668C
(en)
*
|
1996-11-25 |
2005-08-23 |
Alza Corporation |
Methylphenidate tablet
|
US5788987A
(en)
|
1997-01-29 |
1998-08-04 |
Poli Industria Chimica Spa |
Methods for treating early morning pathologies
|
IT1291652B1
(it)
*
|
1997-04-24 |
1999-01-19 |
Apr Trading Sa |
Composizioni farmaceutiche a copertura terapeutica programmata
|
US6962997B1
(en)
*
|
1997-05-22 |
2005-11-08 |
Celgene Corporation |
Process and intermediates for resolving piperidyl acetamide steroisomers
|
DE19747261A1
(de)
*
|
1997-10-25 |
1999-04-29 |
Bayer Ag |
Osmotisches Arzneimittelfreisetzungssystem
|
US8524277B2
(en)
|
1998-03-06 |
2013-09-03 |
Alza Corporation |
Extended release dosage form
|
US5945123A
(en)
*
|
1998-04-02 |
1999-08-31 |
K-V Pharmaceutical Company |
Maximizing effectiveness of substances used to improve health and well being
|
KR100827254B1
(ko)
*
|
1998-06-03 |
2008-05-07 |
알자 코포레이션 |
연장된 약물 치료를 제공하기 위한 방법 및 장치
|
US6524620B2
(en)
|
1998-07-20 |
2003-02-25 |
Andrx Pharmaceuticals, Inc. |
Diltiazem controlled release formulation and method of manufacture
|
AU5062099A
(en)
*
|
1998-07-21 |
2000-02-14 |
Alpenstock Holdings Limited |
An antilipemic formulation
|
US20010055613A1
(en)
*
|
1998-10-21 |
2001-12-27 |
Beth A. Burnside |
Oral pulsed dose drug delivery system
|
DE69939748D1
(de)
|
1998-11-02 |
2008-11-27 |
Elan Pharma Int Ltd |
Multipartikuläre zusammensetzung von methylphenidat mit modifizierter freisetzung
|
US6419960B1
(en)
|
1998-12-17 |
2002-07-16 |
Euro-Celtique S.A. |
Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
|
US6387403B1
(en)
|
1999-09-15 |
2002-05-14 |
Alza Corporation |
Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing
|
US6610674B1
(en)
*
|
1999-09-28 |
2003-08-26 |
University Of Pennsylvania |
Method of treating inflammatory conditions with progesterone analogs
|
ES2374717T3
(es)
|
1999-10-29 |
2012-02-21 |
Euro-Celtique S.A. |
Formulaciones de hidrocodona de liberación controlada.
|
US20060153914A1
(en)
*
|
1999-12-10 |
2006-07-13 |
Biovail Laboratories International S.R.L. |
Chronotherapeutic diltiazem formulations and the administration thereof
|
US7108866B1
(en)
|
1999-12-10 |
2006-09-19 |
Biovall Laboratories International Srl |
Chronotherapeutic diltiazem formulations and the administration thereof
|
ES2302705T3
(es)
*
|
1999-12-23 |
2008-08-01 |
Pfizer Products Inc. |
Forma de dosificacion de farmaco distribuido por un hidrogel.
|
JP2003518487A
(ja)
|
1999-12-23 |
2003-06-10 |
ファイザー・プロダクツ・インク |
ヒドロゲル駆動型積層薬物製剤
|
US7732404B2
(en)
|
1999-12-30 |
2010-06-08 |
Dexcel Ltd |
Pro-nanodispersion for the delivery of cyclosporin
|
WO2002036099A1
(en)
*
|
2000-10-30 |
2002-05-10 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
US20110104214A1
(en)
|
2004-04-15 |
2011-05-05 |
Purdue Pharma L.P. |
Once-a-day oxycodone formulations
|
KR100892333B1
(ko)
*
|
2001-07-10 |
2009-04-08 |
테바 파마슈티컬 인더스트리즈 리미티드 |
0차, 0차-2상, 증가적 또는 감소적 약물 전달을 위한 약물전달 시스템
|
US6863901B2
(en)
*
|
2001-11-30 |
2005-03-08 |
Collegium Pharmaceutical, Inc. |
Pharmaceutical composition for compressed annular tablet with molded triturate tablet for both intraoral and oral administration
|
US6827946B2
(en)
*
|
2001-12-05 |
2004-12-07 |
Collegium Pharmaceutical, Inc. |
Compositions containing both sedative and non-sedative antihistamines
|
EP1492509A1
(en)
*
|
2001-12-18 |
2005-01-05 |
ALZA Corporation |
Dosage form providing time-varying patterns of drug delivery
|
US20040052843A1
(en)
*
|
2001-12-24 |
2004-03-18 |
Lerner E. Itzhak |
Controlled release dosage forms
|
NZ534104A
(en)
*
|
2001-12-24 |
2007-03-30 |
Teva Pharma |
Dosage form with a core tablet of active ingredient sheathed in a compressed annular body of powder or granular material
|
AU2003234216A1
(en)
*
|
2002-04-29 |
2003-11-17 |
Alza Corporation |
Methods and dosage forms for controlled delivery of oxycodone
|
US20050106249A1
(en)
*
|
2002-04-29 |
2005-05-19 |
Stephen Hwang |
Once-a-day, oral, controlled-release, oxycodone dosage forms
|
RU2004134728A
(ru)
*
|
2002-05-31 |
2005-06-10 |
Алза Корпорейшн (Us) |
Дозированные формы и композиции для осмотической доставки различных дозировок оксикодона
|
AR039744A1
(es)
*
|
2002-06-26 |
2005-03-09 |
Alza Corp |
Metodos y formas de dosificacion para aumentar la solubilidad de las composiciones de farmacos para la administracion controlada
|
US20040005359A1
(en)
*
|
2002-06-27 |
2004-01-08 |
Cheng Xiu Xiu |
Controlled release oral dosage form
|
US20050232995A1
(en)
|
2002-07-29 |
2005-10-20 |
Yam Nyomi V |
Methods and dosage forms for controlled delivery of paliperidone and risperidone
|
DK1539115T3
(da)
*
|
2002-07-29 |
2008-01-28 |
Alza Corp |
Fremgangsmåder og doseringsformer til kontrolleret levering af paliperidon
|
JP2005536568A
(ja)
*
|
2002-07-29 |
2005-12-02 |
アルザ・コーポレーシヨン |
トピラメートの調節分配用の調剤および投薬形態
|
US20050208132A1
(en)
*
|
2002-07-29 |
2005-09-22 |
Gayatri Sathyan |
Methods and dosage forms for reducing side effects of benzisozazole derivatives
|
AU2003250707A1
(en)
*
|
2002-07-31 |
2004-02-23 |
Phafag Ag |
A pharmaceutical formulation and its use in the treatment of inner ear diseases
|
US6913768B2
(en)
*
|
2002-09-24 |
2005-07-05 |
Shire Laboratories, Inc. |
Sustained release delivery of amphetamine salts
|
WO2004054542A2
(en)
|
2002-12-13 |
2004-07-01 |
Durect Corporation |
Oral drug delivery system comprising high viscosity liquid carrier materials
|
US8293799B2
(en)
*
|
2003-12-29 |
2012-10-23 |
Osmotica Keresleedelmo és Szolgáltató KFT |
Osmotic device containing a venlafaxine salt and a salt having an ion in common
|
US20070077301A1
(en)
*
|
2002-12-23 |
2007-04-05 |
Meyer Glenn A |
Venlafaxine osmotic device formulation
|
KR20050095835A
(ko)
*
|
2003-01-14 |
2005-10-04 |
알자 코포레이션 |
조정된 점성층을 갖는 방법 및 제형
|
CA2515641A1
(en)
*
|
2003-02-11 |
2004-08-26 |
Alza Corporation |
Methods and dosage forms with modified layer geometry
|
US7632521B2
(en)
*
|
2003-07-15 |
2009-12-15 |
Eurand, Inc. |
Controlled release potassium chloride tablets
|
US20050058707A1
(en)
*
|
2003-08-06 |
2005-03-17 |
Iran Reyes |
Uniform delivery of topiramate over prolonged period of time with enhanced dispersion formulation
|
US20050136108A1
(en)
*
|
2003-08-22 |
2005-06-23 |
Yam Noymi V. |
Stepwise delivery of topiramate over prolonged period of time
|
EP1701697A2
(en)
*
|
2003-09-02 |
2006-09-20 |
ALZA Corporation |
Novel drug compositions and dosage forms of topiramate
|
AU2004275835B2
(en)
|
2003-09-26 |
2011-06-23 |
Alza Corporation |
Controlled release formulations exhibiting an ascending rate of release
|
CA2540056C
(en)
*
|
2003-09-26 |
2015-03-24 |
Alza Corporation |
Controlled release formulations of opioid and nonopioid analgesics
|
ATE544447T1
(de)
|
2003-09-26 |
2012-02-15 |
Alza Corp |
Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
|
JP2007524652A
(ja)
*
|
2003-09-26 |
2007-08-30 |
アルザ・コーポレーシヨン |
アルプラゾラムの制御送達のための浸透性投薬形態物
|
AU2004285532A1
(en)
*
|
2003-10-31 |
2005-05-12 |
Alza Corporation |
Administration of levodopa and carbidopa
|
CA2550866A1
(en)
*
|
2003-12-23 |
2005-07-14 |
Alza Corporation |
Methods and dosage forms for increasing solubility of drug compositions for controlled delivery
|
CA2551815A1
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation |
Novel drug compositions and dosage forms
|
WO2005065648A2
(en)
*
|
2003-12-29 |
2005-07-21 |
Alza Corporation, Inc., |
Novel drug compositions and dosage forms of topiramate
|
US20050175696A1
(en)
*
|
2003-12-29 |
2005-08-11 |
David Edgren |
Drug granule coatings that impart smear resistance during mechanical compression
|
US20050239830A1
(en)
*
|
2004-04-26 |
2005-10-27 |
Vikram Khetani |
Methods of diminishing co-abuse potential
|
WO2006007323A2
(en)
*
|
2004-06-28 |
2006-01-19 |
Alza Corporation |
Dosage forms for low solubility and/or low dissolution rate free acid pharmaceutical agents
|
US8541026B2
(en)
*
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
AR053986A1
(es)
|
2004-12-03 |
2007-05-30 |
Osmotica Pharmaceutical Argent |
Dispositivo osmotico que contiene amantadina y una sal osmotica
|
CA2591247A1
(en)
*
|
2004-12-09 |
2006-06-15 |
Celgene Corporation |
Treatment of patients suffering from a disease having a family history or diagnosis of tics or tourette's syndrome with d-threo methylphenidate
|
DE602006003639D1
(de)
*
|
2005-01-27 |
2008-12-24 |
Alza Corp |
Orale osmotische darreichungsform mit membran mit hoher flussdichte
|
EP1874269A2
(en)
*
|
2005-04-19 |
2008-01-09 |
Alza Corporation |
Combination of tramadol and substances that comprise gabapentin
|
CN101291652A
(zh)
*
|
2005-06-29 |
2008-10-22 |
阿尔扎公司 |
对渗透剂型提供降低的干燥时间的半渗透性组合物
|
WO2007106111A2
(en)
*
|
2005-07-01 |
2007-09-20 |
Elan Pharma International Limited |
Nanoparticulate and controlled release compositions comprising nilvadipine
|
WO2007019393A2
(en)
*
|
2005-08-04 |
2007-02-15 |
Alza Corporation |
Osmotic dosage forms comprising semipermeable membranes with polymer blends providing improved properties
|
US8778395B2
(en)
*
|
2005-08-11 |
2014-07-15 |
Andrx Labs, Llc |
Diltiazem controlled release formulation and method of manufacture
|
US20070190137A1
(en)
*
|
2005-10-07 |
2007-08-16 |
Reyes Iran |
Osmotic dosage form with controlled release and fast release aspects
|
PL116330U1
(en)
*
|
2005-10-31 |
2007-04-02 |
Alza Corp |
Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
|
US20070196487A1
(en)
*
|
2006-02-16 |
2007-08-23 |
Geerke Johan H |
Method and apparatus for drilling orifices in osmotic tablets incorporating near-infrared spectroscopy
|
KR101495146B1
(ko)
|
2006-03-16 |
2015-02-24 |
트리스 파마 인코포레이티드 |
약물 - 이온교환 수지 복합체를 함유하는 변형 방출 제제
|
TW200815045A
(en)
*
|
2006-06-29 |
2008-04-01 |
Jazz Pharmaceuticals Inc |
Pharmaceutical compositions of ropinirole and methods of use thereof
|
WO2008021875A2
(en)
*
|
2006-08-08 |
2008-02-21 |
Accu-Break Technologies, Inc. |
Pharmaceutical tablets containing a plurality of active segments
|
WO2008084698A1
(ja)
|
2006-12-28 |
2008-07-17 |
Astellas Pharma Inc. |
タクロリムス徐放性医薬組成物
|
US8524749B2
(en)
*
|
2007-02-09 |
2013-09-03 |
Alza Corporation |
Controlled release compositions of tizanidine
|
WO2008105920A1
(en)
*
|
2007-02-28 |
2008-09-04 |
Collegium Pharmaceutical, Inc. |
Antihistamine combination
|
WO2009075782A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
|
JP2011511782A
(ja)
|
2008-02-12 |
2011-04-14 |
アボット・ラボラトリーズ |
長期放出性ヒドロコドンアセトアミノフェンならびにその関連方法および用途
|
CN102316730A
(zh)
*
|
2008-05-09 |
2012-01-11 |
天雅瑞药业有限公司 |
用于减轻全身性炎症和/或血管炎症的n-乙酰半胱氨酸(nac)的控释
|
CA2730561A1
(en)
*
|
2008-07-30 |
2010-03-18 |
Panacea Biotec Limited |
Modified release ramipril compositions and uses thereof
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
WO2010077925A2
(en)
|
2008-12-16 |
2010-07-08 |
Teva Pharmaceutical Industries Ltd. |
Drug delivery system for zero order, zero order biphasic, ascending or descending drug delivery of methylphenidate
|
US8568793B2
(en)
*
|
2009-02-11 |
2013-10-29 |
Hope Medical Enterprises, Inc. |
Sodium nitrite-containing pharmaceutical compositions
|
WO2011032386A1
(zh)
|
2009-09-15 |
2011-03-24 |
北京天衡药物研究院 |
一种渗透泵型控释片及其制备方法
|
WO2011121593A1
(en)
*
|
2010-03-29 |
2011-10-06 |
Hetero Research Foundation |
Stable pharmaceutical composition of imatinib
|
WO2011122524A1
(ja)
|
2010-03-29 |
2011-10-06 |
アステラス製薬株式会社 |
放出制御医薬組成物
|
US8287903B2
(en)
|
2011-02-15 |
2012-10-16 |
Tris Pharma Inc |
Orally effective methylphenidate extended release powder and aqueous suspension product
|
CA2859241C
(en)
*
|
2012-01-17 |
2019-01-29 |
Croda, Inc. |
Seal swell additive comprising sorbitol diester
|
BR112015003120B1
(pt)
|
2012-08-15 |
2022-08-09 |
Tris Pharma , Inc |
Tablete mastigável de liberação estendida de metilfenidato e seu uso
|
WO2014144975A1
(en)
|
2013-03-15 |
2014-09-18 |
Durect Corporation |
Compositions with a rheological modifier to reduce dissolution variability
|
CA2902911C
(en)
|
2014-10-31 |
2017-06-27 |
Purdue Pharma |
Methods and compositions particularly for treatment of attention deficit disorder
|
US11590228B1
(en)
|
2015-09-08 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine compositions
|
US9707217B1
(en)
|
2017-02-03 |
2017-07-18 |
Osmotica Kereskedelmi Es Szolgaltato Kft |
Dose-dumping resistant controlled release dosage form
|
US11590081B1
(en)
|
2017-09-24 |
2023-02-28 |
Tris Pharma, Inc |
Extended release amphetamine tablets
|
JP2021513987A
(ja)
|
2018-02-16 |
2021-06-03 |
エスペリオン・セラピューティクス・インコーポレイテッドEsperion Therapeutics, Inc. |
ベンペド酸の持続放出製剤
|
EP3735228B1
(en)
|
2018-03-05 |
2022-01-05 |
Amneal Complex Products Research LLC |
Programmable pharmaceutical compositions for chrono drug release
|
US10722473B2
(en)
|
2018-11-19 |
2020-07-28 |
Purdue Pharma L.P. |
Methods and compositions particularly for treatment of attention deficit disorder
|
US11547670B2
(en)
|
2019-03-05 |
2023-01-10 |
Amneal Complex Products Research Llc |
Delayed release methylphenidate compositions
|
CN114681422B
(zh)
*
|
2020-12-30 |
2023-09-05 |
深圳翰宇药业股份有限公司 |
一种硝苯地平控释片及其制备方法
|